Company Ticker News January 28, 2022Better Biotech Stock: CRISPR Therapeutics or Twist Bioscience? 0 0 Share
Company Ticker News January 9, 2022Why CRISPR Therapeutics Stock Sank 50.5% in 2021 and Continues to Fall 0 0 Share
Company Ticker News January 8, 2022CRISPR Therapeutics AG (CRSP) Gains As Market Dips: What You Should Know 0 0 Share
Company Ticker News December 30, 2021Cathie Wood's ARK Invest Buys Nearly 60,000 Shares of CRISPR 0 0 Share
Company Ticker News December 25, 2021CRISPR Therapeutics AG (CRSP) Outpaces Stock Market Gains: What You Should Know 0 0 Share
Press Release December 24, 2021CRISPR Therapeutics AG (CRSP) Outpaces Stock Market Gains: What You Should Know 0 0 Share
Company Ticker News December 3, 2021CRISPR Therapeutics AG's (CRSP) CEO Sam Kulkarni at Piper Sandler 33rd Annual Virtual Healthcare Conference (Transcript) 0 0 Share
Press Release November 22, 2021CRISPR Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to CTX110™ for the Treatment of Relapsed or Refractory CD19+ B-cell malignancies 0 0 Share
Company Ticker News November 22, 2021Do CRISPR Therapeutics and Intellia Face a Big Safety Risk? 0 0 Share
